NCT06675513View on ClinicalTrials.gov

Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 18, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2029

Conditions
CRC (Colorectal Cancer)Metastatic Colorectal Cancer
Interventions
BIOLOGICAL

An armored GCC targeting WD-01 CAR-T to treat cancer patients Other Name:

"Autologous WD-01 CAR-T therapy with Wondercel's Warrior armor strategy will be explored for its advantage over other armor platforms."

Trial Locations (2)

710054

RECRUITING

Anhui Provincial Cancer Hospital, Hefei

Unknown

RECRUITING

Huazhong University of Science and Technology Union Hospital (Nanshan Hospital), Shenzhen

All Listed Sponsors
lead

Wondercel Biotech (ShenZhen)

INDUSTRY

NCT06675513 - Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter